Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli
- PMID: 8501323
- DOI: 10.1093/infdis/167.6.1336
Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli
Abstract
The ability of six antibiotics from different classes to release radiolabeled lipopolysaccharide (LPS) from a phenotypically smooth galE mutant of Escherichia coli O111:B4 was examined. Antibiotic concentrations were 0.0625-512 micrograms/mL. LPS release increased as a function of the antibiotic concentration, reaching a limit at or near the concentration that killed the majority of bacteria. The maximum amount of LPS released by polymyxin B was 40.6% +/- 0.9%, by gentamicin 58.2% +/- 2.5%, by ciprofloxacin 65.8% +/- 2.5%, by ceftazidime 73.1% +/- 0.9%, by tetracycline 75.3% +/- 10.0%, and by imipenem 79.7% +/- 2.3%. In timed experiments, ceftazidime released 61.9% +/- 1.2%, imipenem 51.1% +/- 8.8%, and tetracycline 39.7% +/- 4.4% of the LPS within the first hour of incubation, whereas polymyxin B released 13.5% +/- 1.9%, gentamicin 9.8% +/- 3.6%, and ciprofloxacin 12.7% +/- 2.6% of the LPS (P < .05). Fluoro-radiography and immunoblot analyses revealed similar migration patterns for antibiotic-released and cell-bound LPS on SDS-PAGE gels, suggesting similar O-polysaccharide content in the two LPS fractions. The amount and rate of LPS release from an E. coli strain was dependent upon antibiotic class and concentration.
Comment in
-
Influence of antibiotic class and concentration on the percentage of release of lipopolysaccharide from Escherichia coli.J Infect Dis. 1994 Feb;169(2):471-3. doi: 10.1093/infdis/169.2.471. J Infect Dis. 1994. PMID: 8106788 No abstract available.
Similar articles
-
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.J Antimicrob Chemother. 1998 Feb;41(2):163-9. doi: 10.1093/jac/41.2.163. J Antimicrob Chemother. 1998. PMID: 9533457
-
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.Antimicrob Agents Chemother. 1998 Apr;42(4):739-43. doi: 10.1128/AAC.42.4.739. Antimicrob Agents Chemother. 1998. PMID: 9559775 Free PMC article.
-
Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies.J Med Microbiol. 1993 Aug;39(2):100-6. doi: 10.1099/00222615-39-2-100. J Med Microbiol. 1993. PMID: 8345504
-
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.Antimicrob Agents Chemother. 2009 Aug;53(8):3411-5. doi: 10.1128/AAC.00358-09. Epub 2009 Jun 1. Antimicrob Agents Chemother. 2009. PMID: 19487441 Free PMC article.
-
Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.Antimicrob Agents Chemother. 1987 Feb;31(2):230-7. doi: 10.1128/AAC.31.2.230. Antimicrob Agents Chemother. 1987. PMID: 3032093 Free PMC article.
Cited by
-
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.Clin Microbiol Rev. 2006 Apr;19(2):315-37. doi: 10.1128/CMR.19.2.315-337.2006. Clin Microbiol Rev. 2006. PMID: 16614252 Free PMC article. Review.
-
Influence of oxytetracycline susceptibility as a first-line antibiotic on the clinical outcome in dairy cattle with acute Escherichia coli mastitis.J Vet Med Sci. 2019 Jun 6;81(6):863-868. doi: 10.1292/jvms.19-0035. Epub 2019 Apr 10. J Vet Med Sci. 2019. PMID: 30971622 Free PMC article.
-
Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1996 Jan;40(1):247-52. doi: 10.1128/AAC.40.1.247. Antimicrob Agents Chemother. 1996. PMID: 8787917 Free PMC article.
-
Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase.Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G467-75. doi: 10.1152/ajpgi.00364.2009. Epub 2010 May 20. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20489044 Free PMC article.
-
Integrated Transcriptomic and Metabolomic Mapping Reveals the Mechanism of Action of Ceftazidime/Avibactam against Pan-Drug-Resistant Klebsiella pneumoniae.ACS Infect Dis. 2023 Dec 8;9(12):2409-2422. doi: 10.1021/acsinfecdis.3c00264. Epub 2023 Oct 25. ACS Infect Dis. 2023. PMID: 37878861 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical